By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Caladrius Biosciences (Formerly Known As NeoStem, Inc.)  

420 Lexington Ave, Suite 350

New York  New York  10170  U.S.A.
Phone: 212-584-4180 Fax: 425-696-4651


SEARCH JOBS


Industry
Services

Segment
Biotechnology





Company News
Caladrius Biosciences (CLBS) Awarded $12.2 Million Grant From CIRM In Support Of Phase II Clinical Trial Of CLBS03 To Treat Type 1 Diabetes 2/24/2017 8:29:00 AM
Caladrius Biosciences (CLBS) Release: Biotech Announces Addition Of Three Clinical Sites, Including UCSF, For The Ongoing Phase 2 Study Of CLBS03 In T1D 1/25/2017 7:41:35 AM
Caladrius Biosciences (CLBS) Updates Status Of Receipt Of Funds For A Portion Of Previously Announced Private Placement 1/9/2017 7:28:18 AM
Caladrius Biosciences (CLBS) To Host 2016 Third Quarter Financial Results Conference Call On November 7 At 5:00 PM Eastern Time 11/3/2016 11:05:39 AM
Caladrius Biosciences (CLBS) Appoints Gregory R. Brown, MD, To Its Board Of Directors 10/12/2016 8:50:28 AM
Caladrius Biosciences (CLBS) To Present At Upcoming October Conferences 10/4/2016 8:01:52 AM
Caladrius Biosciences (CLBS) Subsidiary, PCT, Announces Five-Year Strategic Manufacturing Services Agreement With Adaptimmune 9/19/2016 8:47:11 AM
Caladrius Biosciences (CLBS) Enters Into Agreements To Raise $25 Million In Common Equity Priced At Market Without Warrants 9/15/2016 8:34:23 AM
Caladrius Biosciences (CLBS) To Present At Upcoming September Conferences 9/8/2016 8:14:19 AM
Caladrius Biosciences (CLBS) Reports 2016 Second Quarter Financial Results 8/10/2016 11:06:52 AM
12345678910...
//-->